Literature DB >> 6350081

Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption.

R Ebert, H Unger, W Creutzfeldt.   

Abstract

The action of watery rat gut extracts on glucose-induced insulin release in anaesthetized rats was examined before and after removal of GIP by immunoadsorption. Infusions of GIP-containing rat gut extracts nearly doubled the insulin release induced by intravenous glucose (1 g X kg -1 X h -1). Peak insulin secretion was 98 +/- 11 mU/l (mean +/- SEM) after intravenous glucose and increased to 178 +/- 16 mU/l following infusion of glucose plus gut extract (p less than 0.005). After injection of GIP antiserum in sufficient amounts to neutralize the GIP activity in the gut extract preparation, the additional insulin release due to the gut extract was reduced by only 30%. After complete removal of GIP from gut extracts by immuno-absorption, more than 50% of the incretin effect remained. These data suggest that the insulinotropic activity of rat gut extracts can only be partially related to GIP. The existence of additional insulinotropic gut factors which may also be released following oral glucose is postulated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6350081     DOI: 10.1007/bf00257346

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

Review 1.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

Review 2.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

3.  Ontogeny and distribution of immunoreactive gastric inhibitory polypeptide (IR-GIP) in rat small intestine.

Authors:  C Gespach; D Bataille; C Jarrousse; G Rosselin
Journal:  Acta Endocrinol (Copenh)       Date:  1979-02

4.  Effects of the gastric inhibitory polypeptide present in impure pancreozymin-cholecystokinin on plasma insulin and glucagon in the rat.

Authors:  A Rabinovitch; J Dupré
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

5.  Stimulation of insulin secretion by gastric inhibitory polypeptide in man.

Authors:  J Dupre; S A Ross; D Watson; J C Brown
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

6.  Gastric inhibitory polypeptide: effect on glucose-induced insulin release from isolated rat pancreatic islets in vitro.

Authors:  P Schauder; J C Brown; H Frerichs; W Creutzfeldt
Journal:  Diabetologia       Date:  1975-10       Impact factor: 10.122

7.  Importance of preabsorptive insulin release on oral glucose tolerance: studies in pancreatic islet transplanted rats.

Authors:  E G Siegel; E R Trimble; A E Renold; H R Berthoud
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

8.  [On radio-immunologic determination of insulin in blood].

Authors:  F Melani; H Ditschuneit; K M Bartelt; H Friedrich; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1965-09-15

9.  Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.

Authors:  D K Andersen; D Elahi; J C Brown; J D Tobin; R Andres
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Secretion of an insulinotropic factor from isolated, perfused rat intestine.

Authors:  S R Levin; M Z Pehlevanian; A E Lavee; R I Adachi
Journal:  Am J Physiol       Date:  1979-06
View more
  14 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005.

Authors:  J J Holst
Journal:  Diabetologia       Date:  2006-01-14       Impact factor: 10.122

Review 3.  The Pancreatic β-Cell: The Perfect Redox System.

Authors:  Petr Ježek; Blanka Holendová; Martin Jabůrek; Jan Tauber; Andrea Dlasková; Lydie Plecitá-Hlavatá
Journal:  Antioxidants (Basel)       Date:  2021-01-29

4.  Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man.

Authors:  L O Uttenthal; O O Ukponmwan; M Ghiglione; S R Bloom
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

Review 5.  New developments in the incretin concept.

Authors:  W Creutzfeldt; R Ebert
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

6.  The Incretins and Pancreatic beta-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus.

Authors:  Mi-Hyun Kim; Moon-Kyu Lee
Journal:  Korean Diabetes J       Date:  2010-02-28

7.  Updating the Role of α-Cell Preproglucagon Products on GLP-1 Receptor-Mediated Insulin Secretion.

Authors:  Darleen Sandoval
Journal:  Diabetes       Date:  2020-11       Impact factor: 9.461

8.  Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.

Authors:  M Nauck; F Stöckmann; R Ebert; W Creutzfeldt
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

Review 9.  Incretins, insulin secretion and Type 2 diabetes mellitus.

Authors:  T Vilsbøll; J J Holst
Journal:  Diabetologia       Date:  2004-02-13       Impact factor: 10.122

10.  Effect of monoclonal antibodies to enteroglucagon on ileal adaptation after proximal small bowel resection.

Authors:  M Gregor; H Menge; R Stössel; E O Riecken
Journal:  Gut       Date:  1987       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.